Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
49.9M
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
41.7M
-
Shares change
-
-3.79M
-
Total reported value, excl. options
-
$73.5M
-
Value change
-
-$125M
-
Number of buys
-
47
-
Number of sells
-
-53
-
Price
-
$1.76
Significant Holders of HilleVax, Inc. - Common Stock, par value $0.0001 per share (HLVX) as of Q3 2024
114 filings reported holding HLVX - HilleVax, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
HilleVax, Inc. - Common Stock, par value $0.0001 per share (HLVX) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.7M shares
of 49.9M outstanding shares and own 83.72% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (10.6M shares), TAKEDA PHARMACEUTICAL CO LTD (6.72M shares), TANG CAPITAL MANAGEMENT LLC (4.92M shares), BlackRock, Inc. (2.13M shares), FRANKLIN RESOURCES INC (1.96M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.88M shares), Carlyle Group Inc. (1.84M shares), VANGUARD GROUP INC (1.57M shares), BRAIDWELL LP (1.06M shares), and Balyasny Asset Management L.P. (1.01M shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.